ArticlePDF Available

The prevalence of occult peripheral arterial disease among patients referred for orthopedic evaluation of leg pain

Authors:

Abstract and Figures

Lower extremity peripheral arterial disease (PAD) and musculoskeletal conditions both produce symptoms of leg pain, and may coexist. This study assesses the prevalence of PAD among patients referred to orthopedic surgery for evaluation of lower extremity pain. Fifty consecutive patients aged 50 years or more who had a chief complaint of leg pain, no history of trauma, and no previous history of PAD were studied prospectively. The presence of known risk factors for PAD and classic claudication symptoms was assessed by telephone interview and medical record review. Individuals were then evaluated by measurement of the ankle-brachial index (ABI) using Doppler and pulse volume recordings (PVR). A patient was deemed to have PAD if the ABI was below 0.9 or if the PVR demonstrated significant abnormalities. Occult PAD was detected in 10 of the 50 patients (20%) on the basis of the non-invasive vascular studies. There were no differences between patients with PAD and those without PAD regarding the presence of risk factors for PAD. None of the patients without PAD had claudication, while only one of the 10 patients with PAD had symptoms of classic claudication. In conclusion, 20% of patients referred by primary care providers to the orthopedic surgery clinic for lower extremity pain were discovered to have occult PAD. The majority of these patients did not have claudication. Orthopedic surgeons and primary care providers must maintain an appropriately high index of suspicion for PAD when evaluating patients with non-traumatic lower extremity pain.
Content may be subject to copyright.
http://vmj.sagepub.com/
Vascular Medicine
http://vmj.sagepub.com/content/13/3/235
The online version of this article can be found at:
DOI: 10.1177/1358863X08091970
2008 13: 235Vasc Med
Joseph Bernstein, John L Esterhai, Mitchell Staska, Sally Reinhardt and Marc E Mitchell
of leg pain
The prevalence of occult peripheral arterial disease among patients referred for orthopedic evaluation
Published by:
http://www.sagepublications.com
On behalf of:
Society for Vascular Medicine
can be found at:Vascular MedicineAdditional services and information for
http://vmj.sagepub.com/cgi/alertsEmail Alerts:
http://vmj.sagepub.com/subscriptionsSubscriptions:
http://www.sagepub.com/journalsReprints.navReprints:
http://www.sagepub.com/journalsPermissions.navPermissions:
http://vmj.sagepub.com/content/13/3/235.refs.htmlCitations:
by guest on May 11, 2011vmj.sagepub.comDownloaded from
The prevalence of occult peripheral arterial disease among
patients referred for orthopedic evaluation of leg pain
Joseph Bernstein
1,2
, John L Esterhai
1,2
, Mitchell Staska
2
, Sally Reinhardt
2
and Marc E Mitchell
3
Abstract: Lower extremity peripheral arterial disease (PAD) and musculoskeletal con-
ditions both produce symptoms of leg pain, and may coexist. This study assesses the
prevalence of PAD among patients referred to orthopedic surgery for evaluation of
lower extremity pain. Fifty consecutive patients aged 50 years or more who had a
chief complaint of leg pain, no history of trauma, and no previous history of PAD
were studied prospectively. The presence of known risk factors for PAD and classic
claudication symptoms was assessed by telephone interview and medical record
review. Individuals were then evaluated by measurement of the anklebrachial index
(ABI) using Doppler and pulse volume recordings (PVR). A patient was deemed to
have PAD if the ABI was below 0.9 or if the PVR demonstrated significant abnormali-
ties. Occult PAD was detected in 10 of the 50 patients (20%) on the basis of the non-
invasive vascular studies. There were no differences between patients with PAD and
those without PAD regarding the presence of risk factors for PAD. None of the
patients without PAD had claudication, while only one of the 10 patients with PAD
had symptoms of classic claudication. In conclusion, 20% of patients referred by pri-
mary care providers to the orthopedic surgery clinic for lower extremity pain were
discovered to have occult PAD. The majority of these patients did not have claudica-
tion. Orthopedic surgeons and primary care providers must maintain an appropri-
ately high index of suspicion for PAD when evaluating patients with non-traumatic
lower extremity pain.
Key words: claudication; degenerative joint disease; peripheral artery disease
Introduction
Among older patients presenting to orthopedic sur-
gery for evaluation of lower extremity pain, muscu-
loskeletal conditions such as degenerative joint dis-
ease (DJD) and peripheral arterial disease (PAD)
may be found concurrently; both are afflictions
associated with advanced age. In some patients,
PAD not musculoskeletal disease, may be the
source of their symptoms. In those cases where a
diagnosis of DJD is suspected, it is important to
exclude the possibility of concurrent occult PAD,
especially when surgical treatment for arthritis is
contemplated. There is evidence indicating that pri-
mary care providers may be unaware of PAD in
many patients.
1
Patients presenting to orthopedics
for evaluation of atraumatic lower extremity pain
may have been inadequately assessed for the condi-
tion, and may indeed have undiagnosed PAD. The
purpose of this study is to determine the prevalence
of occult PAD in these patients.
Materials and methods
All new patients 50 years of age or older presenting
to the orthopedic surgery practice at the Philadel-
phia Veterans Affairs Medical Center (VAMC)
between July and December of 2005 were screened
consecutively for possible inclusion in the study.
This practice serves as the primary orthopedic ser-
vice for the hospital and its outpatient clinics, as well
as the tertiary referral service for other nearby
VAMCs. Only patients who have been referred by
another physician are seen; patients cannot refer
themselves to the orthopedic clinic. Patients with a
chief complaint of leg pain and no history of trauma
were contacted by the study nurse to determine
study eligibility. Inclusion criteria for the study
included: aged 50 years or more, leg pain, no history
of trauma within the last 3 years, no previous
1
Department of Orthopedic Surgery, University of
Pennsylvania, Philadelphia, PA, USA;
2
Veterans Affairs
Medical Center, Philadelphia, PA, USA;
3
Department of
Surgery, University of Mississippi, Jackson, MS, USA
Correspondence to: Marc E Mitchell, Professor and Chair,
Department of Surgery, University of Mississippi, 2500 North
State Street, Jackson, MS 39216, USA.
Email: memitchell@surgery.umsmed.edu
Vascular Medicine 2008; 13: 235238
© 2008 SAGE Publications, Los Angeles, London, New Delhi and Singapore 10.1177/1358863X08091970
by guest on May 11, 2011vmj.sagepub.comDownloaded from
history of PAD, and referral to orthopedic surgery
by a primary care provider.
Eligible patients completed a brief telephone
interview regarding risk factors for PAD and symp-
toms of claudication (Table 1). The electronic med-
ical record was also utilized to determine the pres-
ence or absence of risk factors, history of
claudication, previous history of PAD, and presence
or absence of the diagnosis of DJD.
Patients were evaluated in the non-invasive vas-
cular laboratory with pulse volume recordings
(PVRs) and anklebrachial indexes (ABIs). Pressure
measurements and PVRs were obtained at the level
of the proximal thigh, distal thigh, calf and ankle
using a Parks Flo-Lab system (Parks Medical Elec-
tronics, Inc., Aloha, OR, USA). For each leg, the
ABI was calculated as the ratio of the highest ankle
pressure measured (dorsalis pedis or posterior tibial)
to the highest arm pressure measured. These studies
were reviewed by a blinded, board-certified, attend-
ing vascular surgeon both for accuracy and to pro-
vide further vascular surgery consultation if needed.
The study protocol defined PAD as an ABI < 0.9.
Patients with an ABI of 0.9 or above were given the
diagnosis of PAD if PVRs demonstrated significant
arterial occlusive disease by waveform analysis.
Waveform criteria used to make the diagnosis of
PAD included loss of the dicrotic wave, decrease
in the amplitude of the waveform, decrease in the
slope of the up-stroke, decrease in the slope of the
down-stroke, and bowing of the down-stroke away
from the baseline.
Appropriate statistical testing was conducted to
determine differences in risk factors between the
group of patients identified with PAD and the
group without PAD. The protocol was approved
by the institutional IRB and informed consent was
obtained.
Results
Fifty consecutive patients were included in this study.
All were male, with an average age of 63 years (range
5086, standard deviation 10.7). Ten patients were
determined to have occult PAD. Nine had an ABI
below 0.9 and one had an ABI of 0.93, but was given
the diagnosis of PAD based on an abnormal PVR
with significant abnormalities of the arterial wave-
forms. Only one of the 10 patients with PAD had
symptoms consistent with claudication. None of the
40 patients without PAD had claudication.
Twenty-nine of the patients in the sample (58%)
carried the diagnosis of DJD prior to referral for
orthopedic surgery evaluation. Five of the
10 patients in the group with PAD (50%), and 24
of the 40 patients with no PAD (60%) had DJD.
This difference was not statistically significant
(p= 0.83).
The distribution of risk factors is shown in
Table 2. No statistically significant differences in
risk factors were seen between the two groups. The
mean number of risk factors present per patient was
2.4 in the group with PAD versus 2.1 in the group
without PAD. This difference was not statistically
significant (p= 0.45).
Discussion
This study demonstrates that a significant number
of older patients referred to orthopedic surgery for
evaluation of lower extremity pain, have occult
Table 1 Telephone interview protocol
1 Do you consent to be interviewed?
2 Do you have leg pain?
3If yes to number 2
Do you have pain on exertion, with every bout of
activity, that increases with activity and improves
with rest?
4 Have you suffered trauma to the affected leg within
the last 3 years?
5 Have you smoked within the last 10 years?
6 Do you have now or have a history of heart attack or
heart disease, stroke, high blood pressure, diabetes,
peripheral arterial disease, hyperlipidemia?
7 Does anyone in your family have a history of heart
attack or heart disease, peripheral arterial disease,
stroke?
8 Do you agree to undergo vascular testing?
Table 2 Prevalence of risk factors for peripheral arterial disease
Risk factor Prevalence in sample
population n=50
Prevalence in subgroup
with PAD n=10
Prevalence in subgroup
without PAD n=40
Hyperlipidemia 22 (44%) 7 (70%) 15 (38%)
History of cardiac disease 7 (14%) 1 (10%) 6 (15%)
History of stroke 3 (6%) 0 3 (8%)
Smoking within the last 10 years 12 (24%) 4 (40%) 8 (20%)
Diabetes 10 (20%) 3 (30%) 7 (18%)
Hypertension 23 (46%) 5 (50%) 18 (45%)
Family history of myocardial infarction,
stroke or PAD
29 (58%) 4 (40%) 25 (63%)
236 J Bernstein et al.
Vascular Medicine 2008; 13: 235238
by guest on May 11, 2011vmj.sagepub.comDownloaded from
PAD. Furthermore, neither the presence of known
risk factors for PAD, nor symptoms of claudication
were useful predictors of occult PAD in these
patients. Along with prior reports,
15
this study
serves to remind physicians that occult PAD is an
important diagnostic entity, worthy of heightened
clinical suspicion.
It is not surprising that 20% of this group of
patients over the age of 50 were found to have
PAD by non-invasive vascular testing. There have
been many other studies demonstrating a similar
incidence of PAD.
1,3,4
The low incidence of claudi-
cation in these patients with PAD has also been
reported in previous studies.
3,4
It has been previ-
ously demonstrated that 45% of patients with
PAD have coexisting orthopedic disease.
6
It is, how-
ever, interesting that in a group of patients with a
complaint of leg pain severe enough to warrant
referral for an orthopedic surgery evaluation, 20%
were found to have undiagnosed PAD. Although
the majority of these patients did not have symp-
toms of classic claudication, this finding suggests
that despite efforts to increase awareness regarding
PAD, it continues to be underdiagnosed.
The presence of PAD may be an important con-
sideration in the management of patients with DJD.
Radiographically confirmed DJD does not neces-
sarily result in symptoms commensurate with the
severity of the abnormalities seen on imaging
studies.
7
Thus, the mere presence of radiographi-
cally severe DJD may not in and of itself provide a
complete diagnostic explanation for the patients
symptoms. The same can be said of PAD. Clinicians
experienced in the management of PAD are aware
of how difficult it can be to differentiate claudica-
tion from other types of leg pain.
8
This study
demonstrates that coexistent DJD and PAD is not
uncommon, and that the latter is not always recog-
nized prior to orthopedic surgery evaluation. In
patients with both DJD and PAD, it is entirely pos-
sible that neither is responsible for the symptoms.
More sophisticated testing may be required to deter-
mine the cause of the symptoms.
The treating orthopedic surgeon must be attuned
to the possibility of PAD, as this condition may
influence the outcomes of surgical treatment for
arthritis, either by increasing the risk of perioperative
complications, or by constraining the benefits of
treatment. In a series of 18,443 knee replacements
performed at the Mayo Clinic,
9
24 patients (approx-
imately one out of every 750) required above the
knee amputation for complications secondary to vas-
cular disease. In a study by DeLaurentis, et al.,
10
one
out of four patients with demonstrable PAD had
complications of knee replacement attributable
to vascular insufficiency. The association between
PAD and coronary artery disease is well
known.
1113
Patients with coexistent PAD and
DJD may be at increased risk for perioperative car-
diac complications when undergoing major orthope-
dic procedures. The overall mortality risk for knee
replacement surgery is approximately 1 in 200.
Although not specifically addressed in this study,
patients with coexisting PAD are at higher risk for
perioperative cardiac morbidity and mortality. The-
oretically, PAD may also increase the risk of wound
complications or infection among patients undergo-
ing lower extremity orthopedic surgery.
Occult PAD may also mar an otherwise successful
joint replacement procedure. As noted by Stewart
and Baird,
14
symptoms of PAD are seen only if
exercise tolerance is not restricted forthisreason,
patients with disabling arthritis of the knee may not
experience the early symptoms of intermittent claudi-
cation if their exercise tolerance is restricted primarily
by arthritis.There may be a group of patients with
no claudication prior to joint replacement surgery
because they do not walk far enough, who become
severely limited by claudication once their arthritis is
successfully treated. The potential for successful
rehabilitation in these patients following surgery
could be significantly impaired by their PAD.
There are limitations associated with this study:
primarily its location and size. This investigation
was conducted within a VAMC. As such, the
patients were disproportionately male, and may rep-
resent a cohort with greater risk factors for PAD
compared with the general population. It must be
further acknowledged that the small sample size
likely limits the ability to detect differences in risk
factors between the subgroups. Lastly, the study
could have been improved if all patients were sub-
jected to an expert vascular examination, but that
was not logistically feasible.
In conclusion, this study demonstrates that occult
PAD is frequently present in patients with no his-
tory of trauma or claudication, who are referred by
primary care providers to orthopedic surgeons for
evaluation of leg pain. Moreover, the presence or
absence of risk factors for PAD is not a useful dis-
criminator between patients with and those without
PAD. Assessing patients for PAD is neither costly
nor invasive. Based on the current study, physicians
who treat patients with lower extremity pain should
have a low threshold for obtaining lower extremity
non-invasive vascular testing, even in the absence of
symptoms of claudication.
Acknowledgements
Conflicts of interest
None.
PAD prevalence among leg pain orthopedic referrals 237
Vascular Medicine 2008; 13: 235238
by guest on May 11, 2011vmj.sagepub.comDownloaded from
Ethical Board Review
Approved by institutional IRB.
References
1 Hirsch, AT, Criqui, MH, Treat-Jacobson, D, et al. Periph-
eral arterial disease detection, awareness, and treatment in
primary care. JAMA 2001; 286: 13171324.
2 Ouriel, K. Detection of peripheral arterial disease in pri-
mary care. JAMA 2001; 286: 13801381.
3 Meijer, WT, Hoes, AW, Rutgers, D, Bots, ML, Hofman,
A, Grobbee, DE. Peripheral arterial disease in the elderly:
the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998;
18: 185192.
4 Criqui, MH, Fronek, A, Barett-Connor, E, Klauber, MR,
Gabriel, S, Goodman, D. The prevalence of peripheral
arterial disease in a defined population. Circulation 1985;
71: 510515.
5 Hirsch, AT, Haskal, ZJ, Hertzer, NR, et al. ACC/AHA
2005 practice guidelines for the management of patients
with peripheral arterial disease (lower extremity, renal,
mesenteric, and abdominal aortic): executive summary: a
collaborative report from the American Association for
Vascular Surgery/Society for Vascular Surgery, Society for
Cardiovascular Angiography and Interventions, society for
Vascular Medicine and Biology, Society of Interventional
Radiology, and the ACC/AHA Task Force on Practice
Guidelines. Circulation 2006; 113: 14741547.
6 Heidrich, H, Hermann, GM. Concomitant neurological
and orthopaedic diseases in the presence of peripheral arte-
rial disease: a prospective study. Vasa 2006; 35: 101105.
7 Link, TM, Steinbach, LS, Ghosh, S, et al. Osteoarthritis:
MR imaging findings in different stages of disease and cor-
relation with clinical findings. Radiology 2003; 226: 373
381.
8 McDermott, MM, Mehta, S, Greenland, P. Exertional leg
symptoms other than intermittent claudication are common
in peripheral arterial disease. Arch Intern Med 1999; 159:
387392.
9 Sierra, RJ, Trousdale, RT, Pagnano, MW. Above-the-knee
amputation after a total knee replacement: prevalence, eti-
ology, and functional outcome. J Bone Joint Surg Am 2003;
85: 10001004.
10 DeLaurentis, DA, Levitsky, KA, Booth, RE, et al. Arterial
and ischemic aspects of total knee arthroplasty. Am J Surg
1992; 164: 237240.
11 Criqui, MH, Denenberg, JO. The generalized nature of ath-
erosclerosis: how peripheral arterial disease may predict
adverse events from coronary artery disease. Vasc Med
1998; 3: 241245.
12 Golomb, BA, Dang, TT, Criqui, MH. Peripheral arterial
disease: morbidity and mortality implications. Circulation
2006; 114: 688699.
13 Criqui, MH, Langer, RD, Fronek, A, et al. Mortality over
a period of 10 years in patients with peripheral arterial dis-
ease. N Engl J Med 1992; 326: 381386.
14 Stewart, AH, Baird, RN. The prevention and early recog-
nition of arterial complications in total knee replacement: a
vascular surgical perspective. Knee 2001; 8: 265267.
238 J Bernstein et al.
Vascular Medicine 2008; 13: 235238
by guest on May 11, 2011vmj.sagepub.comDownloaded from
... In this same cohort, only 2% had symptomatic PVD. 13 In a recent nationwide database cohort study, 1,547,092 who underwent TKA were investigated for a diagnosis of PVD. In this cohort, the prevalence of PVD was 20%. ...
... The resting ankle-brachial systolic pressure index (ABI) is a simple, well-studied test to evaluate the extent of PVD in patients undergoing TKA. [1][2][3]9,13,15,18,23,45 The ABI is a ratio of the ankle systolic blood pressure divided by the brachial systolic pressure detected with a Doppler probe. 46 It is an effective test at diagnosing PVD being highly sensitive (90%) and specific (98%). ...
Article
Peripheral vascular disease (PVD), defined as decreased arterial perfusion to the lower extremities due to atherosclerotic obstruction, is known to occur in patients undergoing total knee arthroplasty with described rates of between 2% and 4.5% PVD is of significance for patients undergoing TKA as it can increase wound healing and infection complications after TKA and is an independent risk factor for arterial complications following TKA. Our goal is to provide a comprehensive review of the pathophysiology of PVD as it relates to TKA, associated outcomes of patients undergoing TKA in the setting of PVD, diagnostic pearls, and current management strategies recommended in the published literature.
... PAD is confirmed by measuring the ankle-brachial index (ABI) but this method remains underutilized, 11 and PAD remains an under-diagnosed condition in the primary care setting. 12,13 Delayed diagnosis of PAD contributes to high rates of morbidity, limb amputation and death. 14 ABI is the ratio of blood pressure (BP) at the ankle to BP in the arm and is the gold standard for PAD diagnosis. ...
... 29 However, PAD remains an under-diagnosed and undertreated disease. 12,13 For the present study, we used the ABI test as the gold standard for comparison for development and validation of the NLP algorithm for PAD. We have previously applied the NLP-PAD algorithm in PAD patients who did not undergo ABI testing 30 and the rules derived from that process have also been incorporated in the final version of the algorithm used in the present study. ...
Article
Full-text available
Peripheral arterial disease (PAD) is a chronic disease that affects millions of people worldwide and yet remains underdiagnosed and undertreated. Early detection is important, because PAD is strongly associated with an increased risk of mortality and morbidity. In this study, we built a PAD surveillance system using natural language processing (NLP) for early detection of PAD from narrative clinical notes. Our NLP algorithm had excellent positive predictive value (0.93) and identified 41% of PAD cases before the initial ankle-brachial index (ABI) test date while in 12% of cases the NLP algorithm detected PAD on the same date as the ABI (the gold standard for comparison). Hence, our system ascertains PAD patients in a timely and accurate manner. In conclusion, our PAD surveillance NLP algorithm has the potential for translation to clinical practice for use in reminding clinicians to order ABI tests in patients with suspected PAD and to reinforce the implementation of guideline recommended risk modification strategies in patients diagnosed with PAD.
... PAD is confirmed by measuring the ankle-brachial index (ABI) but this method remains underutilized, 11 and PAD remains an under-diagnosed condition in the primary care setting. 12,13 Delayed diagnosis of PAD contributes to high rates of morbidity, limb amputation and death. 14 ABI is the ratio of blood pressure (BP) at the ankle to BP in the arm and is the gold standard for PAD diagnosis. ...
... 29 However, PAD remains an under-diagnosed and undertreated disease. 12,13 For the present study, we used the ABI test as the gold standard for comparison for development and validation of the NLP algorithm for PAD. We have previously applied the NLP-PAD algorithm in PAD patients who did not undergo ABI testing 30 and the rules derived from that process have also been incorporated in the final version of the algorithm used in the present study. ...
Conference Paper
Full-text available
Peripheral arterial disease (PAD) is a chronic disease that affects millions of people worldwide though this condition remains underdiagnosed and undertreated. Early detection is very important, because PAD is strongly associated with an increased risk of mortality and morbidity. In this study, we built a PAD surveillance system using natural language processing (NLP) for early detection of PAD from narrative clinical notes. Our NLP system had excellent positive predictive value (0.93) and identified 41% of PAD cases before initial ABI test date while in 12% of cases the system had the same date as ankle-brachial index (ABI), the gold standard for comparison. Hence, our system ascertains PAD patients in timely and accurate manner.
... Screening for PAD is important for two main reasons. First, the majority of patients with PAD are asymptomatic, even in symptomatic patients atypical symptoms are common 3,5,7,8 . Moreover, asymptomatic disease can significantly increase the rate of progression to intermittent claudication, which could adversely affect the quality of life 9,10 . ...
... The study revealed that the prevalence of PAD is around 20%. Other studies reported similar or higher prevalence 3,4,6,7,26 . The prevalence in this study is higher than that found by Al Mahroos et al 17 . ...
Article
Objective: The aim of this study is to use ankle-brachial index (ABI) to evaluate the prevalence of peripheral arterial disease (PAD) in diabetic patients and to identify the associated cardiovascular risk factors and their level of control. Design: Cross-sectional Study. Setting: Four primary healthcare centers. Method: Four health centers were chosen randomly. People attending diabetes clinics were screened for PAD by measuring their ABI. ABI ≤ 0.9 was used to diagnose PAD. In addition, patients' medical records were reviewed for PAD risk factors including age, smoking, blood pressure, glycated hemoglobin, lipid profile, chronic kidney disease (CKD) and the use of guardian drugs. Further, self-reported data about presence of classical claudication symptoms were obtained. Result: Three hundred thirty-one patients were included in the study. One hundred fiftytwo (45.9%) patients were females. PAD was present in 67 (20.2%) patients. Classical claudication symptoms were present in 13 (19.4%) PAD patients. Clinical profile and the use of guardian drugs in the group was poor in general, but was worse among PAD patients. Statistically significant association was found between low ABI and stage ≥ 3 CKD (P=0.014). Use of statins was lower in patients with PAD when compared with patients with normal ABI (P=00). Conclusion: The study revealed that PAD is highly prevalent among people with diabetes. Control of cardiovascular risk factors was poor in general, but was worse in patients with PAD. The use of guardian drugs was suboptimal.
... Patients with PAD are either asymptomatic or complain of atypical symptoms. So screening is essential to reach the right diagnosis [7]. Asymptomatic disease can progress to the symptomatic phase, with intermittent claudication, which could negatively affect the quality of life [8]. ...
Article
Full-text available
Aim: The aim of this study was to assess the prevalence of micro- and macrovascular disease in Egyptian patients with diabetes mellitus (DM) and peripheral arterial disease (PAD). Methods: The study included 161 Egyptian patients with DM and PAD (91.3% had type 2 DM and 67.1% were females). Mean diabetes duration was 14.2 ± 5.2 years. Full history, clinical and fundus examination as well as laboratory investigations were done. PAD was diagnosed through assessment of ankle/brachial index (ABI) by Doppler ultrasonography. Results: ABI was <0.9 in 33.5% and >1.3 in 66.5% of patients. A significant positive correlation was found between abnormal ABI and diabetes duration, ischemic heart disease (IHD), diabetic retinopathy and neuropathy, foot ulcers, elevated blood pressure (BP), creatinine, urine albumin/creatinine ratio (ACR) and triglycerides and a significant negative correlation with HDL. Multivariate regression analysis revealed that the independent predictors for PAD in patients with ABI< 0.9 were neuropathy, creatinine, triglyceride, LDL, urine ACR and low HDL, and in patients with ABI >1.3 were IHD, neuropathy, elevated diastolic BP and triglyceride. Conclusion: The risk of micro- and macrovascular disease is high in Egyptian patients with diabetes and PAD. Early diagnosis and good control of risk factors could reduce PAD progression.
... The coexistence of arthropathy and PAD is common. 31 Ankle, knee, and hip discomfort may be confused with or additive to symptoms caused by PAD. Clues such as a previous injury or localized swelling at a joint can provide insight into the abnormalities. ...
Article
How best to approach a patient with peripheral arterial disease (PAD) can be an intimidating and confusing task. There are few disease processes as variable in location, presentation, and severity as those seen in the vasculopath. There are many etiologies to be considered simultaneously. Ironically, it is the variability of PAD that provides an opportunity to extract a comprehensive and tightly integrated history and physical examination that is nearly unparalleled in medicine. Similarly, there are few disease processes that offer the opportunity to impact so many aspects of the patient, literally from head to toe. This article, part of a series on PAD, focuses on the initial assessment and evaluation of the PAD, with pathophysiology, genetics, and treatment addressed in accompanying articles. Each patient with PAD is unique (Table 1). Even though the pathophysiology, risk factors, location, and eventual treatment options for a patient often prove routine, the manner in which the patient presents is anything but predictable.1 We have all had the experience of taking a well-structured history (Table 2) from a textbook patient, presented to an attending physician or a colleague, and then watched and listened in disbelief as the confirmatory history is nothing at all similar to what was heard 15 minutes earlier. Unfortunately, patients do not often read the textbook. As demonstrated by McDermott and colleagues,2 the discomfort caused by PAD is more often atypical than typical. Descriptions such as “tired,” “giving way,” “sore,” and “hurts” are offered more often than “cramp.” This forces the healthcare provider to meticulously clarify the location, quality, and circumstances of the discomfort. It is not unusual that a patient reports ≥2 types and locations of discomfort. Careful consideration for pain from both orthopedic and neurogenic sources must be taken. Each symptom should be individually addressed and clarified. These …
Article
Peripheral artery disease (PAD) is a common progressive atherosclerotic occlusive disease that causes insufficient blood flow to the lower extremities. The symptom that health care professionals most often associate with PAD is claudication. However, patient reporting of claudication is highly variable. A structured literature review was conducted to evaluate how PAD symptoms are identified, defined, and categorized. This review focuses on the development and performance characteristics of PAD symptom questionnaires and the identification of a spectrum of leg symptoms beyond classic claudication. Additionally, potential confounders of PAD symptom reporting and strategies for a more comprehensive assessment of PAD symptoms are discussed. Overall, there is a lack of consistency in the utilization of PAD claudication questionnaires which impacts PAD symptom reporting and categorization. Based on this review, atypical symptoms are commonly reported, but poorly understood. Additional research is needed to gain a better understanding of the presentation of atypical symptoms, as well as the role of age, gender, race, and comorbid conditions on the symptom experience of patients with PAD.
Article
Peripheral arterial disease (PAD) is a strong marker of cardiovascular disease but remains an under-diagnosed problem. Moreover, PAD frequently leads to foot problems requiring particular care and surveillance. The aims of this study were (1) to determine the prevalence of undiagnosed PAD in a cohort of asymptomatic subjects referred to a podiatric clinic and (2) to evaluate whether a four-item form assessing medical history for the presence of cardiovascular risk factors could identify subjects at high risk for asymptomatic PAD. This study included 717 consecutive subjects (121 males, age 50.9±13.9 y) referring to a podiatric clinic who were asymptomatic for PAD and free of cardiovascular disease. The ankle brachial index (ABI) was measured in all subjects. Each subject also completed a self-administered form to identify cardiovascular risk factors. Among the entire cohort, the prevalence of PAD was 8.3% in males and 1.2% in females. Three subgroups were identified according to the number of risk factors reported (no risk factors, one risk factor, and two or more risk factors), and the prevalence of PAD differed between each subgroup (0.2%, 3.2%, and 18.9%, respectively; p < 0.001). In an unselected cohort of subjects referring to a podiatric clinic, who were asymptomatic for PAD and free from cardiovascular diseases, a remarkable prevalence of PAD was found among subjects reporting a minimum of two cardiovascular risk factors. In a podiatric setting, screening with a self-administered form for the presence of cardiovascular risk factors might lead to an early diagnosis of PAD.
Article
Arterial complications associated with total knee arthroplasty (TKA), although infrequent, may be associated with the following sequelae: infection, limb loss, and rarely, death. When revascularization is undertaken in the postoperative setting, additional complications may be encountered including postischemic reperfusion injury necessitating prophylactic fasciotomies. The end result is a prolonged postoperative course leading to worse functional outcome. A preoperative history and physical examination performed by the orthopedic surgeon can determine if the patient is at increased risk for vascular complications and whether the at-risk limb can withstand the stress of the operation. Consideration should be given to obtaining ankle-brachial indexes in this patient population, noting that arterial calcification may elevate the value. This article presents a case of an immediate preoperative vascular examination, performed at the time of surgical site marking, in an at-risk patient prior to TKA. We detail the clinical course of a patient with peripheral vascular disease and indwelling superficial femoral artery stent, who developed stent thrombosis in the 2-week period between his last clinic visit and date of surgery, with no change in symptoms. This restenosis was detected on routine preoperative physical examination and resulted in cancellation of the TKA in the preoperative area, allowing the patient to undergo emergent revascularization. We emphasize the importance of an immediate preoperative vascular examination in the setting of TKA and provide a comprehensive review of the literature with guidelines on the perioperative management of antiplatelet agents and appropriate use of the tourniquet.
Article
Full-text available
Context Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis that is common and is associated with an increased risk of death and ischemic events, yet may be underdiagnosed in primary care practice.Objective To assess the feasibility of detecting PAD in primary care clinics, patient and physician awareness of PAD, and intensity of risk factor treatment and use of antiplatelet therapies in primary care clinics.Design and Setting The PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, a multicenter, cross-sectional study conducted at 27 sites in 25 cities and 350 primary care practices throughout the United States in June-October 1999.Patients A total of 6979 patients aged 70 years or older or aged 50 through 69 years with history of cigarette smoking or diabetes were evaluated by history and by measurement of the ankle-brachial index (ABI). PAD was considered present if the ABI was 0.90 or less, if it was documented in the medical record, or if there was a history of limb revascularization. Cardiovascular disease (CVD) was defined as a history of atherosclerotic coronary, cerebral, or abdominal aortic aneurysmal disease.Main Outcome Measures Frequency of detection of PAD; physician and patient awareness of PAD diagnosis; treatment intensity in PAD patients compared with treatment of other forms of CVD and with patients without clinical evidence of atherosclerosis.Results PAD was detected in 1865 patients (29%); 825 of these (44%) had PAD only, without evidence of CVD. Overall, 13% had PAD only, 16% had PAD and CVD, 24% had CVD only, and 47% had neither PAD nor CVD (the reference group). There were 457 patients (55%) with newly diagnosed PAD only and 366 (35%) with PAD and CVD who were newly diagnosed during the survey. Eighty-three percent of patients with prior PAD were aware of their diagnosis, but only 49% of physicians were aware of this diagnosis. Among patients with PAD, classic claudication was distinctly uncommon (11%). Patients with PAD had similar atherosclerosis risk factor profiles compared with those who had CVD. Smoking behavior was more frequently treated in patients with new (53%) and prior PAD (51%) only than in those with CVD only (35%; P <.001). Hypertension was treated less frequently in new (84%) and prior PAD (88%) only vs CVD only (95%; P <.001) and hyperlipidemia was treated less frequently in new (44%) and prior PAD (56%) only vs CVD only (73%, P<.001). Antiplatelet medications were prescribed less often in patients with new (33%) and prior PAD (54%) only vs CVD only (71%, P<.001). Treatment intensity for diabetes and use of hormone replacement therapy in women were similar across all groups.Conclusions Prevalence of PAD in primary care practices is high, yet physician awareness of the PAD diagnosis is relatively low. A simple ABI measurement identified a large number of patients with previously unrecognized PAD. Atherosclerosis risk factors were very prevalent in PAD patients, but these patients received less intensive treatment for lipid disorders and hypertension and were prescribed antiplatelet therapy less frequently than were patients with CVD. These results demonstrate that underdiagnosis of PAD in primary care practice may be a barrier to effective secondary prevention of the high ischemic cardiovascular risk associated with PAD. Figures in this Article Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic syndrome that affects approximately 8 to 12 million individuals in the United States and is associated with significant morbidity and mortality.1- 4 Because of its high prevalence, high rates of nonfatal cardiovascular ischemic events (myocardial infarction [MI], stroke, and other thromboembolic events), increased mortality, and diminution of quality of life, the consequences of PAD in US communities are significant.1- 5 A regional pilot study of community screening for PAD demonstrated that patient awareness of the PAD diagnosis was low and associated with low atherosclerosis risk factor, antiplatelet, and claudication treatment intensity.5 There have been no national efforts in the United States to detect PAD in community-based office practice, to assess both physician and patient awareness of the diagnosis, or to assess the intensity of medical treatments. PAD has not emerged as a focus of public health efforts to improve quality of life nor to decrease the associated cardiovascular ischemic risk. The PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program was designed as a national investigation to assess the feasibility of detecting PAD using the ankle-brachial index (ABI) in office-based practices. Additional goals were to assess both patient and physician awareness of PAD, to evaluate the magnitude of the associated atherosclerosis risk factor burden, and to assess the intensity of use of risk-reduction strategies in community practice. The program evaluated the following hypotheses: (1) that PAD is prevalent but underdiagnosed in primary care practices and (2) that PAD is undertreated in terms of risk factor modification and use of antiplatelet therapies compared with that in other cardiovascular diseases (CVDs).
Article
Prospective and retrospective analyses of 1,182 consecutive patients undergoing primary total knee arthroplasty (TKA) were performed to determine (1) the incidence of chronic lower extremity ischemia (CLEI); (2) the effect of tourniquet occlusion; and (3) guidelines that will allow TKA to be performed safely. Despite the appropriately advanced age of our patients, the incidence of CLEI was only 2%. All ischemic complications occurred in six patients with CLEI (25%), but none resulted in death or amputation. The ischemic complications consisted of pressure-induced necrosis of toes, heel, or foot, atheroembolism, femoral-popliteal graft occlusion, and asymptomatic popliteal occlusion. Tourniquet compression in the 1,158 patients without CLEI produced no untoward effects. Patients with mild CLEI can have a TKA performed safely with a tourniquet if there is no femoropopliteal calcification. When the ischemia is severe or there is a femoropopliteal aneurysm, arterial reconstruction should precede the TKA. In patients with patent femoral-popliteal bypasses or calcification without ischemia, TKA should be performed without a tourniquet. Ischemic pressure necrosis is an additional mechanism of injury.
Article
Previous investigators have observed a doubling of the mortality rate among patients with intermittent claudication, and we have reported a fourfold increase in the overall mortality rate among subjects with large-vessel peripheral arterial disease, as diagnosed by noninvasive testing. In this study, we investigated the association of large-vessel peripheral arterial disease with rates of mortality from all cardiovascular diseases and from coronary heart disease. We examined 565 men and women (average age, 66 years) for the presence of large-vessel peripheral arterial disease by means of two noninvasive techniques--measurement of segmental blood pressure and determination of flow velocity by Doppler ultrasound. We identified 67 subjects with the disease (11.9 percent), whom we followed prospectively for 10 years. Twenty-one of the 34 men (61.8 percent) and 11 of the 33 women (33.3 percent) with large-vessel peripheral arterial disease died during follow-up, as compared with 31 of the 183 men (16.9 percent) and 26 of the 225 women (11.6 percent) without evidence of peripheral arterial disease. After multivariate adjustment for age, sex, and other risk factors for cardiovascular disease, the relative risk of dying among subjects with large-vessel peripheral arterial disease as compared with those with no evidence of such disease was 3.1 (95 percent confidence interval, 1.9 to 4.9) for deaths from all causes, 5.9 (95 percent confidence interval, 3.0 to 11.4) for all deaths from cardiovascular disease, and 6.6 (95 percent confidence interval, 2.9 to 14.9) for deaths from coronary heart disease. The relative risk of death from causes other than cardiovascular disease was not significantly increased among the subjects with large-vessel peripheral arterial disease. After the exclusion of subjects who had a history of cardiovascular disease at base line, the relative risks among those with large-vessel peripheral arterial disease remained significantly elevated. Additional analyses revealed a 15-fold increase in rates of mortality due to cardiovascular disease and coronary heart disease among subjects with large-vessel peripheral arterial disease that was both severe and symptomatic. Patients with large-vessel peripheral arterial disease have a high risk of death from cardiovascular causes.
Article
Because patients with peripheral arterial disease (PAD) may be asymptomatic or may present with atypical symptoms or findings, the true population prevalence of PAD is essentially unknown. We used four highly reliable, sophisticated noninvasive tests (segmental blood pressure, flow velocity by Doppler ultrasound, postocclusive reactive hyperemia, and pulse reappearance half-time) to assess the prevalence of large-vessel PAD and small-vessel PAD in an older (average age 66 years) defined population of 613 men and women. A total of 11.7% of the population had large-vessel PAD on noninvasive testing, and nearly half of those with large-vessel PAD also had small-vessel PAD (5.2%). An additional 16.0% of the population had isolated small-vessel PAD. Large-vessel PAD increased dramatically with age and was slightly more common in men and in subjects with hyperlipidemia. Isolated small-vessel PAD, by contrast, was essentially unrelated to sex, hyperlipidemia, or age, although it was somewhat less common before age 60. Intermittent claudication rates in this population were 2.2% in men and 1.7% in women, and abnormalities in femoral or posterior tibial pulse were present in 20.3% of men and 22.1% of women compared with the noninvasively assessed large-vessel PAD rate of 11.7%. Thus assessment of large-vessel PAD prevalence by intermittent claudication dramatically underestimated the true large-vessel PAD prevalence and assessment by peripheral pulse examination dramatically overestimated the true prevalence.
Article
To assess the age- and sex-specific prevalence of peripheral arterial disease (PAD) and intermittent claudication (IC) in an elderly population, we performed a population-based study in 7715 subjects (40% men, 60% women) aged 55 years and over. The presence of PAD and IC was determined by measuring the ankle-arm systolic blood pressure index (AAI) and by means of the World Health Organization/Rose questionnaire, respectively. PAD was considered present when the AAI was <0.90 in either leg. The prevalence of PAD was 19.1% (95% confidence interval, 18.1% to 20.0%): 16.9% in men and 20.5% in women. Symptoms of IC were reported by 1.6% (95% confidence interval, 1.3% to 1.9%) of the study population (2.2% in men, 1.2% in women). Of those with PAD, 6.3% reported symptoms of IC (8.7% in men, 4.9% in women), whereas in 68.9% of those with IC an AAI below 0.90 was found. Subjects with an AAI <0.90 were more likely to be smokers, to have hypertension, and to have symptomatic or asymptomatic cardiovascular disease compared with subjects with an AAI of 0.90 or higher. The authors conclude that the prevalence of PAD in the elderly is high whereas the prevalence of IC is rather low, although both prevalences clearly increase with advancing age. The vast majority of PAD patients reports no symptoms of IC.
Article
Non-invasive measurements, especially segmental pressure ratios and flow measurements, are useful for gauging the severity of peripheral arterial disease (PAD). Although the incidence of PAD is similar for men and women, men are more likely to have severe disease, while women usually have more moderate or asymptomatic disease. Published reports confirm the clinical impression that patients with PAD are more likely to have both coronary artery disease and cerebrovascular disease than those without PAD. However, the degree of overlap is a function of the sensitivity of the diagnostic assessments for the three conditions. A San Diego population study found that the incidence of PAD may be underestimated, with many patients being asymptomatic. Based on blood flow measurements, the study found that 11.9% of the study population had large vessel PAD. Morbidity from both coronary heart disease and stroke was increased in people with PAD, who were 2.5 times more likely to present with morbidity from cardiovascular disease (CVD) than those who did not have PAD. Several studies have now confirmed the strong predictive value of PAD for subsequent CVD mortality and that the risk of CVD mortality increases with the severity of PAD.
Article
Epidemiological data show that most community-dwelling men and women with lower-extremity peripheral arterial disease (PAD) do not have typical symptoms of intermittent claudication. We compared the prevalence of intermittent claudication, leg symptoms other than intermittent claudication, and absence of exertional leg symptoms between patients with PAD identified from a blood flow laboratory (group 1), patients with PAD in a general medicine practice (group 2), and control patients without PAD (group 3). Numbers of participants in groups 1, 2, and 3 were 137, 26, and 105, respectively. Patients with previously diagnosed PAD were excluded from groups 2 and 3. All participants underwent ankle-brachial index measurement and were administered the San Diego claudication questionnaire to assess leg symptoms. Within groups 1, 2, and 3, prevalences of intermittent claudication were 28.5% (n = 39), 3.8% (n = 1), and 3.8% (n= 4), respectively. Prevalences of exertional leg symptoms other than intermittent claudication were 56.2% (n= 77), 42.3% (n= 11), and 19.0% (n = 20), respectively. Absence of exertional leg symptoms was reported by 15.3% (n= 21), 53.8% (n= 14), and 77.1% (n=81), respectively. Among patients with PAD, older age, male sex, diabetes mellitus, and group 2 vs group 1 status were associated independently with absence of exertional leg symptoms in multivariable regression analysis. Lower ankle-brachial index levels and group 1 vs group 2 status were associated with intermittent claudication. Clinical manifestations of PAD are diverse, particularly among patients identified by ankle-brachial index screening. Exertional leg symptoms other than intermittent claudication are common in PAD. Patients with PAD who are older, male, diabetic, or identified with ankle-brachial index screening in a primary care setting are more likely to have asymptomatic PAD.
Article
Peripheral arterial disease (PAD) encompasses those entities that result in arterial occlusions in vessels other than those of the coronary and intracranial vascular beds. Although PAD includes the extracranial carotid, upper extremity, visceral, and renal circulation, the term is usually applied to disease involving the circulation of the lower extremity alone. Intermittent claudication, heralded by pain in the leg muscles during ambulation, is the earliest and the most classic symptom among patients with PAD.¹ As the severity of arterial occlusion progresses, symptoms occur even at rest and may culminate in lower extremity ulceration and gangrene. Major amputation is eventually required in more than one third of patients once such limb-threatening symptoms and signs occur.² Moreover, all-cause mortality is closely linked with the presence and severity of PAD,³ reaching 20% annually in patients with limb-threatening manifestations.⁴ Nevertheless, the cause of death in patients with PAD is seldom a direct result of the lower extremity arterial disease. Most patients die from complications of coronary artery disease or cerebrovascular disease, with fewer than 10% of deaths from peripheral vascular events.⁵